Argenx Se (ARGX) EBITDA Margin (2016 - 2026)
Argenx Se's (ARGX) quarterly EBITDA Margin came in at 32.54% in Q2 2026, up 1135.0% on a YoY basis from 2.63% in Q2 2025, and up 7.2% quarter-over-quarter from 30.35% in Q1 2026.
Powered by 
Analysis
Argenx Se (ARGX) EBITDA Margin (2016 - 2026) Analysis & Trends
Argenx Se (ARGX) has reported EBITDA Margin for 11 consecutive years, with 32.54% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBITDA Margin rose 1135.0% year-over-year to 32.54%; the trailing twelve-month figure through Jun 2026 stood at 30.63% (up 1563.0% YoY), and the FY2025 full-year result was 25.38%, up 2638.0% from the prior year.
- EBITDA Margin rose to 32.54% in Q2 2026 per ARGX's latest filing, from 30.35% in the prior quarter.
- Across five years, EBITDA Margin topped out at 113.83% in Q2 2022 and bottomed at 1052.43% in Q1 2022.
- Historically, EBITDA Margin has averaged 64.78% across 5 years, with a median of 3.52% in 2024.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin plunged 105242 bps in 2022, then surged 100485 bps in 2023.
- Over 5 years, EBITDA Margin stood at 65.99% in 2022, then jumped by 44 bps to 37.03% in 2023, then jumped by 138 bps to 13.98% in 2024, then jumped by 104 bps to 28.59% in 2025, then increased by 14 bps to 32.54% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 32.54%, 30.35%, and 28.59% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 37.40% |
| 10 | Argenx Se | 58.53 Bn | 53.35 Bn | 1.37 Bn | 32.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.54% |
| Mar 31, 2026 | 30.35% |
| Dec 31, 2025 | 28.59% |
| Sep 30, 2025 | 30.72% |
| Jun 30, 2025 | 21.20% |
| Mar 31, 2025 | 17.59% |
| Dec 31, 2024 | 13.98% |
| Sep 30, 2024 | 2.48% |
| Jun 30, 2024 | -9.52% |
| Mar 31, 2024 | -23.46% |
| Dec 31, 2023 | -37.03% |
| Sep 30, 2023 | -24.49% |
| Jun 30, 2023 | -37.91% |
| Mar 31, 2023 | -47.58% |
| Dec 31, 2022 | -65.99% |
| Sep 30, 2022 | -158.87% |
| Jun 30, 2022 | 113.83% |
| Mar 31, 2022 | -1,052.43% |
| Dec 31, 2021 | -887.37% |
| Sep 30, 2021 | 829.05% |
API Access
Argenx Se EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ARGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ARGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ARGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();